No Data
No Data
Chongqing Pharscin Pharmaceutical (SZSE:002907) Earnings and Shareholder Returns Have Been Trending Downwards for the Last Five Years, but the Stock Rallies 7.0% This Past Week
Pharscin Pharmaceutical Gets Nod to Market Agomelatine
Pharscin Pharmaceutical Obtains Production License After Passing GMP Inspection
We Think That There Are More Issues For Chongqing Pharscin Pharmaceutical (SZSE:002907) Than Just Sluggish Earnings
Pharscin Pharmaceutical Gets Nod to Re-Register API and Drugs
Chongqing Pharscin Pharmaceutical Co., Ltd.'s (SZSE:002907) Market Cap Rose CN¥401m Last Week; Private Companies Who Hold 45% Profited and so Did Insiders
No Data